FDA - Biosimilars and Interchangeable Biologic Products


Thursday, September 24, 2020 (3pm - 4pm US/Eastern)


This is a member-only webinar.*

The Food and Drug Administrationís Center for Evaluation and Research is a key player in approving biological therapeutics and generic drugs in the United Statesí prescription drug market. The agency has approved nearly thirty biosimilars in the past five years, and these medications provide more choice and lower costs for patients and employer plans.

Please join ERIC and experts from the Center for Evaluation and Research as they discuss the regulatory and scientific concepts of biosimilars, current policies, and resources that will benefit employers.

To register for the webinar, click on the "Register Now" link at the top of this page (you will need your username and password to register).

*If you are not a member and would like to participate in the webinar, please contact ERIC at 202-789-1400 or e-mail: memberservices@eric.org.

The slides for this webinar will be posted to this site on the morning of the call in the View Meeting Documents section.

Related Web Pages and Sites:
https://my.demio.com/ref/AYLYWAbcWMG71y4w